Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative Disorder × Other hematologic neoplasm × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 182 Precursor Cell Lymphoblastic Leukemia-Lymphoma 88 Leukemia, Lymphocytic, Chronic, B-Cell 75 Hematologic Neoplasms 75 Myelodysplastic Syndromes 67 Leukemia 47 Lymphoma 40 Leukemia, Myelomonocytic, Chronic 29 Lymphoma, Non-Hodgkin 28 Burkitt Lymphoma 26 Multiple Myeloma 22 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 20 Leukemia, Biphenotypic, Acute 20 Recurrence 19 Myeloproliferative Disorders 19 Lymphoma, Large B-Cell, Diffuse 19 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 18 Lymphoma, Mantle-Cell 18 Lymphoma, B-Cell, Marginal Zone 18 Neoplasms 17 Lymphoma, Follicular 17 Hodgkin Disease 14 Waldenstrom Macroglobulinemia 13 Lymphoma, B-Cell 12 Myelodysplastic-Myeloproliferative Diseases 10 Leukemia, B-Cell 10 Hematologic Diseases 9 Anemia, Refractory, with Excess of Blasts 9 Primary Myelofibrosis 7 Melanoma 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡